| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 research v0.71 | FCGR2B | Catherine Snow changed review comment from: Comment on list classification: No link to viral susceptibility some evidence of FCGR2B some evidence that variants give rise to susceptibility to develop auto-immune diseases (PMID: 26683154); to: Comment on list classification: No link to viral susceptibility some evidence of FCGR2B that variants give rise to susceptibility to develop auto-immune diseases (PMID: 26683154) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.71 | FCGR2B | Catherine Snow changed review comment from: Comment on list classification: No link to viral susceptibility some evidence of FCGR2B some evidence that variants give rise to susceptibility to develop auto-immune diseases; to: Comment on list classification: No link to viral susceptibility some evidence of FCGR2B some evidence that variants give rise to susceptibility to develop auto-immune diseases (PMID: 26683154) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.71 | FCGR2B | Catherine Snow Classified gene: FCGR2B as Red List (low evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.71 | FCGR2B | Catherine Snow Added comment: Comment on list classification: No link to viral susceptibility some evidence of FCGR2B some evidence that variants give rise to susceptibility to develop auto-immune diseases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.71 | FCGR2B | Catherine Snow Gene: fcgr2b has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.36 | FCGR2B |
Ellen McDonagh gene: FCGR2B was added gene: FCGR2B was added to Viral susceptibility. Sources: Expert Review Red,ESID Registry 20171117 Mode of inheritance for gene: FCGR2B was set to Unknown Phenotypes for gene: FCGR2B were set to Fc receptor deficiencies |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||